Veterinary Medicines

Macrotil Oral, 250 mg/ml suukaudse lahuse kontsentraat vasikatele, sigadele, kanadele ja kalkunitele

Authorised
  • Tilmicosin
Download as PDF

Product identification

Medicine name:
Macrotil Oral, 250 mg/ml suukaudse lahuse kontsentraat vasikatele, sigadele, kanadele ja kalkunitele
Active substance:
  • Tilmicosin
Target species:
  • Cattle (pre-ruminant)
  • Pig
  • Chicken
  • Turkey
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Tilmicosin
    250.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Concentrate for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Cattle (pre-ruminant)
      • Meat and offal
        42
        day
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        14
        day
    • Chicken
      • Meat and offal
        12
        day
    • Turkey
      • Meat and offal
        19
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Interchemie Werken De Adelaar Eesti AS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Interchemie Werken De Adelaar Eesti AS
Responsible authority:
  • RAVIMIAMET
Authorisation number:
  • 2157
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 26/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."